Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121686052 | 12168605 | 2 | F | 20160706 | 20160310 | 20160712 | EXP | CA-ABBVIE-16P-028-1579267-00 | ABBVIE | RIZEK P, IKEDA K, MELE T, ET AL. BOWEL ISCHEMIA IN REFRACTORY STATUS EPILEPTICUS: REPORT OF TWO CASES AND REVIEW OF THE LITERATURE. NEUROCRIT CARE. 2016;24:128-131. | 58.00 | YR | F | Y | 0.00000 | 20160712 | OT | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121686052 | 12168605 | 1 | PS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | U | UNKNOWN | 18081 | |||||||||
| 121686052 | 12168605 | 2 | SS | ISOFLURANE. | ISOFLURANE | 1 | Respiratory (inhalation) | U | UNKNOWN | 0 | INHALATION SOLUTION | ||||||||
| 121686052 | 12168605 | 3 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intramuscular | U | UNKNOWN | 0 | SOLUTION FOR INJECTION | ||||||||
| 121686052 | 12168605 | 4 | SS | PHENYTOIN. | PHENYTOIN | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 121686052 | 12168605 | 5 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Oral | U | UNKNOWN | 0 | TABLET | ||||||||
| 121686052 | 12168605 | 6 | SS | PHENOBARBITAL. | PHENOBARBITAL | 1 | Unknown | U | UNKNOWN | 0 | 150 | MG | SOLUTION FOR INJECTION | Q12H | |||||
| 121686052 | 12168605 | 7 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 0 | 4 | G | INJECTION | ||||||
| 121686052 | 12168605 | 8 | SS | PROPOFOL. | PROPOFOL | 1 | Unknown | U | UNKNOWN | 0 | EMULSION FOR INFUSION | ||||||||
| 121686052 | 12168605 | 9 | SS | KETAMINE | KETAMINE | 1 | Intramuscular | U | UNKNOWN | 0 | SOLUTION FOR INJECTION | ||||||||
| 121686052 | 12168605 | 10 | C | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121686052 | 12168605 | 1 | Seizure |
| 121686052 | 12168605 | 2 | Seizure |
| 121686052 | 12168605 | 3 | Seizure |
| 121686052 | 12168605 | 4 | Seizure |
| 121686052 | 12168605 | 5 | Seizure |
| 121686052 | 12168605 | 6 | Seizure |
| 121686052 | 12168605 | 7 | Product used for unknown indication |
| 121686052 | 12168605 | 8 | Seizure |
| 121686052 | 12168605 | 9 | Seizure |
| 121686052 | 12168605 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121686052 | 12168605 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121686052 | 12168605 | Abdominal distension | |
| 121686052 | 12168605 | Cardiomegaly | |
| 121686052 | 12168605 | Drug ineffective | |
| 121686052 | 12168605 | Hypotension | |
| 121686052 | 12168605 | Intestinal ischaemia | |
| 121686052 | 12168605 | Intra-abdominal pressure increased | |
| 121686052 | 12168605 | Left ventricular hypertrophy | |
| 121686052 | 12168605 | Necrosis ischaemic | |
| 121686052 | 12168605 | Perforation | |
| 121686052 | 12168605 | Pneumatosis | |
| 121686052 | 12168605 | Systemic inflammatory response syndrome | |
| 121686052 | 12168605 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |